Avignon, 16 February 2011 - Naturex, the global leader in speciality plant-based natural ingredients, announces that its securities will be eligible for the "long-only" DSS on NYSE Euronext Paris, starting on 16 February 2011.
A service making it possible to benefit from the leverage effect and from a deferred settlement
Within the framework of its programme for developing liquidity in the regulated market, NYSE Euronext Paris has updated the list of securities that have a minimum daily transaction volume of 100,000 euros, eligible for the "long-only" DSS.
The Deferred Settlement Service allows investors to benefit from the leverage effect as well as from a deferred settlement. It is as such possible to purchase securities without immediately settling the entire amount and to take maximum advantage of an expected increase; the securities are settled at the end of the trading month.
The notion of "long-only" means that these securities are eligible only for purchase, which eliminates the risk of downward speculative movements on the securities, linked to the short sale principle.
Enhanced attractiveness for the Naturex security
This admission to the "long-only" DSS will participate in increasing the daily volume traded and the liquidity of the Naturex security, and will consequently encourage its visibility and its attractiveness in the financial community, in France as well as abroad.
In 2010, nearly 1,300,000 Naturex securities were traded, for a total of 46 million euros in capital.
If you would like to receive financial information about Naturex by e-mail, go to: www.naturex.fr
Upcoming publications and eventsConsolidated yearly results :31 March 2011 Midcap Event Frankfurt : 7 - 8 March 2011 Midcap Event Brussels : 31 March - 1 April 2011 Paris SFAF Meeting : 4 April 2011
NATUREX has been listed on segment B of NYSE Euronext Paris since October 1996
|Number of shares in the capital: 6,410,931
4,959,935 ordinary shares (ISIN FR0000054694)
1,450,996 preferred shares (ISIN FR0000010833251)
Naturex is part of the following indexes: SBF250, CAC All Shares, CAC Mid&Small 190, CAC Small 90, Gaïa Index
Naturex is eligible for the "long-only" DSS on NYSE Euronext Paris.
MNEMO: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP
Naturex is the global leader in speciality plant-based natural ingredients.
The Group, organised around three strategic markets - Food & Beverage, Nutrition & Health and Personal Care - produces and markets specialty plant-based natural ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.
Naturex's head office is based in Avignon. The company employs more than 950 people and has high-performance industrial resources through its 11 industrial sites in Europe (France, Italy, Spain, the United Kingdom and Switzerland), as well as in Morocco, the United States, Brazil and Australia. It also benefits from sales presence around the world through a dedicated network in 16 countries (France, Italy, Spain, the United Kingdom, Belgium, Germany, Switzerland, Russia, U.A.E., Thailand, Singapore, Japan, China, Australia, the United States and Brazil).
Naturex's sound performance is linked to the fast-growing demand for natural products and its capacity to provide manufacturers with the personalised means to meet the requirements of their end consumers. The Group's strength lies in its ability to position itself on specific products which constitute niche markets, thanks to sustained Research & Development.
Chairman and CEO
Tel.: +33 (0)4 90 23 96 89
Vice-Chairman and CFO
Tel.: +33 (0)4 90 23 96 89
Tel.: +33 (0)4 90 23 78 28
Actus Finance contacts
|Anne Catherine Bonjour
Actus Press Relations
Tel.: +33 (0)1 53 67 36 93
Tel.: +33 (0)1 77 35 04 36
Communiqués au titre de l'obligation d'information permanente :
- Autres communiqués Communiqué intégral et original au format PDF :
http://www.actusnews.com/documents_communiques/ACTUS-0-22750-cp-naturex-en-160211.pdf © Copyright Actusnews Wire
Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com
Receive by email the next press releases of the company by registering on www.actusnews.com, it's free